Background and objective: Cigarette smoke is a leading preventable cause of many diseases and death, because it contains a complex mixture of chemical compounds. Few studies about the relation between cigarette smoking and glycoconjugate were found in literature, while no study was observed regarding passive smokers. Thus this relation is obscure till now. Therefore this work was designed to study the effect of cigarette smoking on serum glycoconjugates levels.
Methods: One hundred twenty one completely healthy males from different areas of Duhok governorate were included in this study. Their age was ranged between 20 and 50 years. They were classified according to the number and duration of cigarette smoking into: heavy smokers (31), moderate smokers (26), passive smokers (30) and non-smokers (control). Fasting blood was withdrawn from all groups and used for determination of serum fucose and its related parameters.
Results: The results showed that there was a significant decrease in serum total protein in heavy smoker groups when compared to non-smokers. The levels of serum total fucose and protein bound fucose significantly increased in smoker groups, while the results indicated that there was a significant increase in serum lipid associated fucose levels in heavy and passive smoker groups comparing to non-smoker group. A significant decrease in serum protein bound hexoses was observed in both heavy and moderate smokers. The result also showed that serum total calcium concentration, Ca/TP and Mg/TP ratios significantly decreased in all smoker groups.Regarding to serum Manganese (Mn) and Mn/TP ratio, their values increased significantly in case of passive smokers only.
Conclusion: The results revealed that cigarette smoking had significant effects on glycoconjugates status (expressed in serum fucose and its related parameters).
Keywords: Cigarette smoking, Fucose, serum elements, glycoconjugate.
1. Romer R. Preventing tobacco use among young people. N Eng J Med1993; 316:1516-21.
2. Pryor WA. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. Environ Health Perspect1997; 105:875-82.
3. RodgmanA, Perfetti TA. The Chemical Components of Tobacco and Tobacco Smoke. Boca Raton (FL): CRC Press, Taylor & Francis Group; 2009.
4. Reznick AZ, Cross CE, Hu ML, Suzuki YJ, Khwaja S, Safadi A, et al. Modification of plasma proteins by cigarette smoke as measured by protein carbonyl formation. Biochem J1992; 286:607-11.
5. Pasupathi P, Bakthavathsalam G, Rao YY, Farook J. Cigarette smoking-Effect of metabolic health risk. Diabetes & Metabolic Syndrome. Clinical Research & Reviews 2009; 3:120-7.
6. ShintonR, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. Br Med J 1989; 298:789-94.
7. Skurnik Y, Shoenfeld Y. Health Effects of Cigarette Smoking. Clinics in Dermatology 1998; 16:545-56.
8. Law M, Morris J, Wald N. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ 1997; 315:973-80.
9. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke nearly as large as smoking. Circulation 2005; 111:2684-98.
10. Maeder T. Sweet medicines. Scientific American 2002; 287:40-7.
11. Omer RM. Effect of Local Injection of α-L-fucose on Rabbit Tongue Muscle, PhD thesis , College of Dentistry, Hawler Medical University, Erbil;2010.
12. Freeze HH .Sweet solution: sugars to the rescue. J Cell Biol 2002; 158:615-6.
13. Nandave M, Ojha SK, Kaur R. Changes in levels of serum glycoproteins in major depressive disorders. Indian Journal of Clinical Biochemistry 2005; 20(2):154-7.
14. ManoharanS, Padmanabhan M, Kolanjiappan K, Ramachandran C R, Suresh K. Analysis of glycoconjugates in patients with oral squamous cell carcinoma. Clinica Chimica Acta 2004; 339:91-6.
15. Block TM, Comunale MA, Low-man M, Steel LF, Romano PR, Fimmel C, et al. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. PNAS 2005; 102(3):779-84.
16. Becker D J, Lowe J B. Fucose biosynthesis and biological function in mammals. Glycobiology 2003; 13(7):41R-53R.
17. Abbass LB, Ahmed SA. Serum Total a-L-fucose and related parameters in breast cancer as tumor marker. Middle East Journal of Family Medicine 2011; 9(11):1-7.
18. Lowe JB. Selectin ligands, leukocyte trafficking, and fucosyltransferase genes. Kidney Int 1997; 51(5):1418–26.
19. Murrey HE, Hsieh-Wilson LC. The Chemical Neurobiology of Carbohydrates. Chem Rev 2008; 108:1708-31.
20. Haddad A. Radioactive fucose as a tool for studying glycoprotein secretion. Braz J Med Biol Res 1998; 13(2):207-13.
21. Daniel JB, John BL. Fucose biosynthesis and biological function in mammals. Glycobiology 2003; 13(7):41-53.
22. Rogers DF,Turner NC, Marriott C, Jeffery PK. Oral N-acetylcysteine or S-carboxymethylcysteine inhibit cigarette for fucosylation in human hepatocellular carcinoma and hepatoma cell Lines. Cancer Res 1989; 63:6282-9.
23. Ayanian JZ, Cleary DP. Perceived risks of heart disease and cancer among cigarette smokers. JAMA1999; 281(11):1019-21.
24. Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949; 77:751-66.
25. Tietz NW. Text book of clinical chemistry, 3rd Ed. Philadelphia: Saunders Publishers; 1995. p.523-4.
26. Dische Z, Shettles LB. Specific colors reactions of methyl pentoses and spectrophotometric micromethod for their determination. J Biol Chem 1948; 175:595-604.
27. Abbas LB. Changes in α-L-fucose and related parameters levels in Leukemia, Ph.D thesis , University of Salahaddin, College of Medicine-Erbil; 2004.
28. Yousif NF. α-L-fucose as a possible diagnostic marker with other related parameters in thyroid dysfunction patients, PhD thesis, College of Ibn Al-Haitham, University of Baghdad, Baghdad; 2005.
29. Katopodis AC, Hirshaut Y, Geller NL, Stock CC. Lipid-associated sialic acid test for the detection of human cancer. Cancer Res1982; 42:5270-5.
30. Zangana Z A. A α-L-Fucose among other biochemical parameters as a possible diagnostic parameter in Thalssemic patients. PhD Thesis , College of Education, Ibn al-haitham, University of Baghdad, 2006.
31. Sershen H, Lajtha A. The effect of nicotine on the metabolism of brain proteins. Neuropharmacology 1979; 18: 763-66.
32. Shetty PK, Pattabiraman TN. Salivary glycoproteins as indicators of oral diseases. Indian Journal of Clinical Biochemistry 2004; 19(1): 97-101.
33. Shah M, Telang S, Raval G, Shah P, Patel P S . Serum fucosylation changes in oral cancer and oral precancerous condition. Alpha-L-Fucosidase as a marker. J Cancer 2008; 113(2): 336-46.
34. Cecioni S, Lalor R, Blanchard B, Praly J, Imberty A, Matthews SE, et al. Achieving High Affinity towards a Bacterial Lectin through Multivalent Topological Isomers of CalixareneGlycoconjugates. Chemistry 2009; 15(47):13232-40.
35. Jorde R, Saleh1 F, FigenschauY, Kamycheva E, Haug E, Sundsfjord J. Serum parathyroid hormone (PTH) levels in smokers andnon-smokers. The fifth Tromsø study. Eur J Endocrinol 2005; 152:39-45
36. Field AE, Colditz GA, Willett WC, Longcope C, Colditz GA. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sexhormone binding globulin in middle-aged men. J Clin Endocrinol Metab 1994; 79:1310-16.
Background and objective: Surgical treatment of condylar diseases involves some problems concerning the choice of the surgical approach to the condylar neck that provides adequate exposure of the area with the least trauma to the facial nerve and parotid tissue. In this paper, personal experience with the surgical treatment of some mandibular condylar neck problems by the preauricular, submandibular and the retromandibular- transmasseteric approaches is reported.
Methods: Over the last 5 years, 52 condylar neck surgeries were carried out on 41 patients to treat 18 cases of condylar neck fractures, 19 cases of plate and bone graft fixation after resection of mandibular tumours and 4 cases of chronic pain and dysfunction of the TMJ. During follow-up, functions of the mandible and facial nerve branches were monitored as does the presence or absence of sialocele or parotid fistula. The appearance of the scar post- surgically and the quality of the access achieved by each type of the approaches to the condylar neck were also appraised.
Results: The incidence of apparent postoperative scar appeared most after the preauricular approach to the condylar neck and least after the submandibular approach. Difficulties in management of condylar neck fractures are found more with the preauricular and least with the retromandibular-transmasseteric approaches. Weaknesses in the branches of the facial nerve are noticed in 50% of the preauricular approaches, 6.89% of the retromandibular-transmasseteric approaches, and 47.36% of the submandibular approaches. In all of the patients, this problem lasted for 3-6 weeks to resolve spontaneously thereafter. All the patients in this work suffered limitation of jaw opening in the early postsurgical period. This problem was a transient one and due to pain and muscle spasm. However, persistent limitation of jaw opening is reported in 13.79% of the retromandibular-transmasseteric approaches and 47.36% of the submandibular approaches to the mandibular condyle.
Conclusion: Experience has shown that the retromandibular-transmasseteric approach to the condylar neck allows for good anatomical repositioning of the fractured condyle and direct access for precise positioning and fixation of the plate or bone graft to achieve satisfactory mandibular function with the least chance of trauma to the facial nerve and parotid tissues.
Keywords: Condylar neck surgery, preauricular, submandibular and retromandibular-transmasseteric approches.
1. Haug RH, Assael LA. Outcomes of open versus closed treatment of mandibular subcondylar fractures. J Oral Maxillofac Surg 2001; 59:370-5.
2. Dolwick MF, Kretzschmar DP. Morbidity associated with the preauricular and perimeatal approaches to the temporo-mandibular joint. J Oral Maxillofac Surg 1982; 40:699-700.
3. Chen CT, Lai JP, TungTC, Chen YR.Endoscopically assisted mandibular subcondylar fracture repair. Plast Reconstr Surg1999; 103:60-5.
4. Vesnaver A, Gorjanc M, Eberlinc A, Dovsak DA, Kansky AA. The periauriculartransparotid approach for open reduction and internal fixation of condylar fractures. J Craniomaxillofac Surg 2005; 33:169-79.
5. Wilson AW, Ethunandan M, Brennan PA,Transmassetericantero-parotid approach for open reduction and internal fixation of condylar fractures. Br J Oral Maxillofac Surg S 2005; 43:57-60
6. Schneider M, Erasmus F, Gerlach KL, Kuhlisch E, Loukota RA, Rasse M. Open reduction and internal fixation versus closed treatment and mandibulomaxillary fixation of fractures of the mandibular condylar process: a randomized, prospective, multicenter study with special evaluation of fracture level. J Oral Maxillofac Surg 2008; 66:2537-44.
7. Langdon JD. Parotid surgery. In Langdon JD, Patel MF, Ord RA, Brennan PA. Operative oral and maxillofacial surgery, 2nd ed. London: Hodder Arnold, an Hachette UK Company; 2011. P. 390.
8. Davis BA, Anson BJ, Budinger JM, Kurth LE. Surgical anatomy of the facial nerve and parotid gland based upon a study of 350 cervicofacial halves. Surg Gynecol Obstet 1956; 102:385-412.
9. Banks P, MacKenenzie I: Condylotomy. A clinical and experimental appraisal of a surgical technique. J Maxillofac Surg 1975; 3:170-81.
10. Marker P, Nielsen A, Lehmann-Bastian H. Fractures of the mandibular condyle. Part 2: Results of treatment of 348 patients. Br J Oral Maxillofac Surg 2000; 38:422-6.
11. Ellis E, McFadden D, Simon P .surgical complications with open treatment of mandibular condylar process fractures. J Oral Maxillofac Surg 2000; 58(9):950-8.
12. Downie JJ, Devlin MF, Carton ATM, Hislop WS. Prospective study of morbidity associated with open reduction and internal fixation of the fractured condyle by the transparotid approach. Br J Oral Maxillofac Surg 2009; 47:370-3.
Background and objective: Dental units, extra oral devices and mini-implants are the main types of anchorage that are used in orthodontic treatment. The aim of this study was to compare between mini-implants and dental unites as anchorage.
Methods: This study used seven dogs wearing orthodontic appliances in the right and left sides of the maxilla for 40 days to retract the 3rd incisors toward the canines. On right side, canine was used as dental anchorage to retract the 3rd incisor by nickel-titanium closed coil spring along a straight arch wire. On the left side, mini-implant between the roots of canine and 1st premolar was used as skeletal anchorage. Different clinical measurements were done on the stone casts and photographs of maxillary dental arch for each dog before and after tooth retraction to assess the effectiveness of each anchorage type on the same animal.
Results: Clinical measurements revealed a highly significant difference between dental and mini-implant sides. The mini-implant side showed less loss of anchorage than dental side, while the extrusion was higher in retracted tooth of mini-implant side than in dental side
Conclusion: This study showed that the mini-implants provide more stable anchorage units than the teeth but cause more extrusion in the moving tooth.
Keywords: Mini-implants, Dental anchorage, Tooth retraction, Dogs.
1. Proffit WR. Contemporary orthodontics, 2nd ed. St Louis: Mosby-year book; 2000. P. 308.
2. Graber LW, Vanarsdall RL, Vig KWL. Orthodontics, current principles and techniques, 5th ed. Philadelphia: Mosby; 2012. P. 13.
3. Deguchi T, Kurosaka H, Oikawa H, Kuroda S, Takahashi I Yamashiro T, et al. Comparison of orthodontic treatment outcomes in adults with skeletal open bite between conventional edgewise treatment and implant-anchored orthodontics. Am J Orthod Dentofacial Orthop 2011; 139:S60-8.
4. Upadhyay M, Yadav S, Nagaraj K, Uribe F, Nanda R. Mini-implant vs fixed functional appliances for treatment of young adult class II female patients. Angle Orthod 2012; 82:294-303.
5. Lee JS, Kim KJ, Park YC, Vanarsdell RL. Applications of orthodontic mini-implants, 1st ed. Canada: Quintessence Publishing; 2007.
6. Yao CCJ, Lai EHH, Chang JZC, Chen I, Chena YJ. Comparison of treatment outcomes between skeletal anchorage and extraoral anchorage in adults with maxillary dentoalveolar protrusion. Am J Orthod Dentofacial Orthop 2008; 134:615-24.
7. Chen F, Terada K, Hananda K, Saito I. Anchorage Effect of Osseointegrated vs. Nonosseointegrated Palatal Implants. Angle Orthod 2006; 76:660-5.
8. Ohashi E, Pecho OE, Moron M, Lagravere MO. Implant vs. Screw Loading Protocols in Orthodontics, A Systematic Review. Angle Orthod 2006; 76:721-7.
9. Asscherickx K, Vannet BV, Wehrbein H, Sabzevar MM. Success rate of miniscrews relative to their position to adjacent roots. Eur J Orthod 2008; 30:330-5.
10. Kim JW, Baek SH, Kim TW, Chang YII. Comparison of Stability between Cylindrical and Conical Type Mini-Implants. Angle Orthod 2008; 78:692-8.
11. Poggio PM, Incorvati C, Velo S, Carano A. ‘‘Safe Zones’’: A guide for mini-screw positioning in the maxillary and mandibular arch. Angle Orthod 2006; 76:191-7.
12. Serra G, Morais LS, Elias CN, Meyers MA, Andrade L, Muller CA, et al. Sequential bone healing of immediately loaded mini-implants: Histomorphometric and fluorescence analysis. Am J Orthod Dentofacial Orthop 2010; 137:80-90.
13. Leung MTC, Rabie ABM, Wong RWK. Stability of connected mini-implants and mini-plates for skeletal anchorage in orthodontics. Eur J Orthod 2008; 30:483-9.
14. Chung KR, Kim SH, Kang YG, Nelson G. Orthodontic mini-plate with tube as an efficient tool for borderline cases. Am J Orthod Dentofacial Orthop 2011; 139:551-62.
15. Cornelis MA, Scheffler NR, De Clerck HJ, Tulloch JF, Behets CN. Systematic review of the experimental use of temporary skeletal anchorage devices in orthodontics. Am J Orthod Dentofacial Orthop 2007; 131:S52-8.
16. Park HM, Kim BH, Yang IH, Baek SH. Preliminary three-dimensional analysis of tooth movement and arch dimension change of the maxillary dentition in Class II division 1 malocclusion treated with first premolar extraction: conventional anchorage vs. mini-implant anchorage. Korean J Orthod 2012; 42(6):280-90.
17. Huja SS, Litsky AS, Beck FM, Jhonson KA, Larsen PE. Pull-out strength of monocortical screws placed in the maxillae and mandibles of dogs. Am J Orthod Dentofac Orthop 2005; 127:307-13.
18. Carrillo R, Buschang PH, Opperman LA, Franco PF, Rossouw PE. Segmental intrusion with mini-screw implant anchorage: A radiographic evaluation. Am J Orthod Dentofacial Orthop 2007; 132:576.e1-576.e6.
19. Koyama I, Iino S, Abe Y, Takano-Yamamoto T, Miyawaki S. Differences between sliding mechanics with implant anchorage and straight-pull headgear and intermaxillary elastics in adults with bimaxillary protrusion. Eur J Orthod 2011; 33:126-31.
20. Ohmae M, Saito S, Morohashi T, Seki K, QU H, Kanomi R, et al. A clinical and histological evaluation of the titanium mini-implants as anchorage for orthodontic intrusion in beagle dogs. Am J Orthod Dentofac Orthop 2001; 119:489-97.
21. Feldmann L, Bondemark L. Anchorage capacity of osseointegrated and conventional anchorage systems: A randomized controlled trial. Am J Orthod Dentofac Orthop 2008; 133: 339.e19-339.e28.
22. Liou EJW, Chang PMH. Apical root resorption in orthodontic patients with en-masse maxillary anterior retraction and intrusion with miniscrews. Am J Orthod Dentofac Orthop 2010; 137:207-12.
23. Motoyoshi M, Uemura M, Ono A, Okazaki K, Shigeeda T, Shimizue N. Factors affecting the long-term stability of orthodontic mini-implants. Am J Orthod Dentofacial Orthop 2010; 137: 588.e1-588.e5.
Background and objective: Nurses have major role in prevention and management of hepatitis B. Aim of the study was to find out the effect of an educational program on nurse' knowledge and practices concerning hepatitis B virus.
Methods: A quasi-experimental study was conducted in emergency hospitals, Erbil city, Iraq from 15th of January to 15th of June 2012 involving 50 nurses. Assessment of the knowledge and practices of nurses was carried out by using a questionnaire developed by the researchers. An educational program was designed, constructed and oriented in order to improve the nurses' knowledge and practices towards hepatitis B virus. Post-test was carried out after the educational program using the same (pre program) questionnaire.
Results: The mean (±SD) score of pre test knowledge was 6.96±1.6, while the mean (±SD) score of post test knowledge was 8.4±1.5 (P<0.001). The educational program has significant effects on nurses' knowledge about main function of liver (P<0.001), complications of renal failure (P=0.002), and avoiding sharing needles and syringes (P=0.013). The post test means (±SD) scores for practices (47±2.46) were significantly higher than the pre-test mean score (43.7±5.16). The educational program had effects on advising practice of hand washing before and after using gloves (P=0.01), using solution for hand washing (P=0.003), risk of contamination with patients' bloods and fluids (P=0.04), removing of gown and washing hands (P=0.012).
Conclusion: The educational program played a significant role in some items which could raise the level of knowledge and practices toward prevention of hepatitis B virus.
Keywords: Hepatitis B, Knowledge, Practices, Educational program.
1. Center for Disease Control: A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Morbidity and Mortality Weekly Report; 2006. 55(RR16):1-25.
2. Koff R. Immunologically mediated extra hepatic manifestations of viral hepatitis. In: Krawitt EL, Wiesner RH, editors. Autoimmune Liver Disease, New York: Raven press; 1991.
3. Shepard CW, Simard EP, Finelli L. Hepatitis B Virus Infection: Epidemiology and Vaccination, Epidemiologic Reviews 2006; 28:112-25.
4. WHO. Hepatitis B, WHO, (Factsheet No. 204), Geneva, (http://www.who.int/mediacentre/ factsheets/fs204/en/, 2008 (accessed 9 May 2013).
5. Kermode M, Jolley D, Langkham B, Thomas MS, Crofts N. Occupational exposure to blood and risk of blood borne virus infection among health care workers in rural north Indian health care settings. Am J Infect Control 2005; 33:34-41.
6. Hou J, Liu Z, Gu F. Epidemiology and Prevention of Review Hepatitis B Virus Infection. Int J Med Sci 2005; 2(1):50-7.
7. South African Vaccination and Immunisation Centre, Clinical Disease hepatitisB. Accessed May 9, 2013. Available from (http://www.savic.ac.za/ disease.php? sub3=88). 2008.
8. Smith DR, Ac Choe M, Jeong J, Jeon MY, Chae YR, An GJ. An epidemiology of needle stick and sharps injuries among professional Korean nurses. J PROF NURS 2006; 22(6):359-66.
9. Satekge MM. Knowledge, attitudes and practices regarding the prevention of hepatitis B virus infections, in final year college student nurses in gauteng province. M.Sc. Thesis. University of Limpopo Medunsa Campus, School of Public Health; 2010.
10. Mohamed SA, Wafa AM. The effective of an educational program on nurse's knowledge and practice related to Hepatitis C Virus: A Pretest and posttest quasi-experimental design. Aust J Basic Appl Sci 2011; 5(11):564-70.
11. Abou Shady, Ibrahim Y, Salem Y. Implementation and evaluation of educational program for nurses regarding nosocomial infection control at Mansoura University Hospital. New Egypt J Med 2001; 24(5):226-33.
12. Anderson JL, Warren CA, Perez. Gender and ethnic differences in hand hygiene practices among college students. Am.J Infect Control 2008; 36(5):361-8.
13. Knight VM, Bodsworth NJ. Perceptions and practices of universal blood and body fluid precautions by registered nurses at a major Sydney teaching hospital. J Adv Nurs 1998; 27(4):746-51.
14. Stein AD, Makarawo TP, Ahmad MF. A survey of doctors' and nurses' knowledge, attitudes andcompliance with infection control guidelines in Birmingham teaching hospitals. J Hosp Infect 2003; 54(1):68-73.
15. Ghahramani F, Mohammadbergi A, MohammadSalehi N. Survey of the Students' Knowledge about Hepatitis in Shiraz University of Medical Sciences. Hepatitis Monthly 2006; 6(2):59-62.
Background and objective: Radiation is used in some aspects of medicine, researches and in industries. These radiation applications are useful to society. However radiation can also have detrimental effects. It was important to establish rules and resolutions governing these uses to balance the positive against the negative effects. Dose limits have been established for groups who use radiation in their work as well as for population at large. The rules used in most countries have been worked out by the International Commission on Radiological Protection (ICRP). The aim of this study was to evaluate the radiation protective measures in different diagnostic radiological departments in Erbil hospitals.
Methods: Data on the number of diagnostic procedures using x-ray examinations in five hospitals were collected. The palm RAD 907 Nuclear Radiation Meter and Contamination Monitor CoMo 170 were used to measure radiation leakage. Questionnaire was also used to elicit information from the most senior personnel of the hospital.
Results: The finding showed that the facilities for safety were grossly inadequate and the dose rates of 16.4μSv/hr and 20μSv/hr were recorded at places for paramedics and technician room respectively. Dose rate in front of window of the monitor room was 113μSv/hr and in the reception was 20μSv/hr indicating higher health risk to the paramedic, visitors and personnel at the hospital.
Conclusion: Radiation protection facilities in the radiological departments of Erbil hospitals are in general poor including both public & private sectors indicating high health risk to the paramedics, visitors and personnel at the hospitals.
Keywords: Radiation protection, Dosimeters, CT-scan, amount of radiation.
1. Daniel A, Seife T, Kalkidan H. Collective radiation dose from diagnostic x-ray examination in nine public hospitals in Addis Ababa, Ethiopia, Ethiop J Health Dev 2010; 24 (2).
2. De González A, Darby S. Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. The Lancet 2004; 363(9406): 345-51.
3. Health Risks of Low Level Radiation Exposure. Indian J Nucl Med 2005; 20(2).
4. International Commission on Radiological Protection. Recommendations of the International Commission on Radiological Protection (ICRP) publication 60. Ann ICRP 1991; 21:1-3.
5. Newlin N. Reduction in radiation exposure: the rare earth screen. AJR 1978;130:1195-6.
6. Daniel P. Plain radiography with rare earth screen, comparison with calcium tungstate screen. AJR 1984; 143:1335-8.
7. Mallam SP, Oladipupo A, Sa’id A. Reappraisal of existing expressions for estimating Radiation output from Diagnostic X-ray machine. Nigerian Journal of physics 2004; 16: 30.
8. Mahogora WE, Nyanda AM. The potential for reduction of radiation doses to patients undergoing some common X-ray examination in Tanzania. Radiat Prot Dosimetry 2000; 94(4):381-4.
9. Washington State University. Safety policies and procedures manual on radiation safety; 2000.
10. Hendry, Jolyon H, Simon et al. Human exposure to high natural background radiation: what can it teach us about radiation risks. J Radiol Prot 2009: 29(2A):29-42.
11. The University of Western Australia. Personal radiation monitoring (updated 23 May, 2003). Available from http://www.safety.uwa.edu.au/page/8744 (Accessed at 13 Jan 2010).
12. Okaro AO , Ohagwu CC, Njoku J. Evaluation of Personnel Radiation Monitoring in Radiodiagnostic Centres in South Eastern Nigeria. African Journal of Basic & Applied Sciences 2009; 2(1-2):49-53.
13. European Commission. European Guidance on Estimating Population Doses from Medical X-ray Procedures. J Radiat Prot 2008; 154.
14. Oluwafisoui PA, Olowookere CJ, Obed RI, Efunwole HO , Akinpelu JA “Environmental Survey and Quality Control Tests of X-Ray Diagnostic Facility of a Large Nigerian Hospital” International Journal of Research and Reviews in Applied Sciences 2009; 1(2):157-62.
Background and objective: A transient ischemic attack is a brief episode of neurological dysfunction resulting from focal cerebral ischemia not associated with permanent cerebral infarction. Transient ischemic attack carries a substantial short-term risk of stroke, hospitalization for cardiovascular events, and death. We aimed to evaluate prognosis of transient ischemic attack within three months follow up period, and identifying the predicting factors.
Methods: Thirty patients with transient ischemic attack were evaluated and followed up for 3 months to identify their prognosis. ABCD2 score was used for risk stratification in index and follow up transient ischemic attack patients.
Results: Within three months of follow up, 10% of patients developed transient ischemic attack and stroke each. There was an association between increasing age and increasing risk of index transient ischemic attack. Hypertension was the highest risk factors for index transient ischemic attack.
Conclusion: Despite standard preventive medications, some patients will still have events later on.
Keywords: prognosis, Transient ischemic attack.
1. Easton JD, Saver JL, Albers GW, Albers MJ, Chaturvedi S, Feldmann E, et al. Definition and evaluation of transient ischemic attack. Stroke 2009; 40:2276-93.
2. Pessin MS, Duncan GW, Mohr JP, Poskanzer DC. Clinical and angiographic features of carotid transient ischemic attacks. N Engl J Med 1977; 296:358-62.
3. Kleindorfer D, Panagos P, Pancioli A,Khoury J, Kissela B, Moomaw C, et al. Incidence and short term prognosis of transient ischemic attack in a population-based study. Stroke 2005; 36:720-3.
4. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000; 284:2901-6.
5. Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJ. North American Symptomatic Carotid Endarterectomy Trial Group. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ 2004; 170:1105-9.
6. Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JN, Warlow CP, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 2005; 366:29-36.
7. Rao SV, Ohman EM, Granger CB, Armstrong PW, Gibler WB, Christenson RH, et al. Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. Am J Cardiol 2003; 91:936-40.
8. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, et al. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke1998; 29:2491-500.
9. Moroney JT, Bagiella E, Paik MC, Sacco RL, Desmond DW. Risk factors for early recurrence after ischemic stroke: the role of strokesyndrome and subtype. Stroke 1998; 29:2118-24.
10. Bath PM, Lindenstrom E, Boysen G, De Deyn P, Friis P, Leys D, et al. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet 2001; 358:702-10.
11. Wiebers DO, Whisnant JP, O’Fallon WM. Reversible ischemic neurologic deficit (RIND) in a community: Rochester, Minnesota. Neurology 1982; 32:459-65.
12. Albers GW, Caplan LR, Easton JD,Fayad PB, Mohr JP, Saver JL, et al. Transient ischemic attack—proposal for a new definition. N Engl J Med. 2002; 347: 1713-6.
13. Johnston SC, Nguyen-Huynh MN, Schwartz ME, Fuller K, Williams CE, Josephson SA. National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol 2006; 60:301-13.
14. Sacco RL, Adams R, Albers G,Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke.2006; 37:577-617.
15. Lavallée PC, Meseguer E, Abboud H,Cabrejo L, Olivot J-M, Simon O, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 2007; 6:953-60.
16. Johnston SC, Smith WS. Practice variability in management of transient ischemic attacks: Epidemiological Impact in the United States of a Tissue-Based Definition of Transient Ischemic Attack. Eur Neurol 1999; 42:105-8.
17. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000; 284:2901-6.
18. Johnston SC, Rothwell PM, Nguyen-Huynh MN,Giles MF, Elkins JS, Bernstein AL, et al. Validation and refinement of scores to predict very early stroke after transient ischaemic attack. Lancet 2007; 369:283-92
19. Orla C, Aine M, Lisa A ,Niamh H, Michael M, Lorraine K, et al. Diagnostic Usefulness of the ABCD2 Score to Distinguish Transient Ischemic Attack and Minor Ischemic Stroke From Noncerebrovascular Events. Stroke 2009; 40: 3449-54.
20. Lewington S, Clarke R, QizilbashN, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-13.
21. Josephson S, Sidney S, Trinh N, Allan L. Bernstein and Johnston S. Higher ABCD2 Score Predicts Patients Most Likely to Have True Transient Ischemic Attack. Stroke 2008; 39;3096-8.
Background and objective: Malondialdehyde is the end product of lipid peroxidation by oxidative stress (free radicals). Superoxide dismutase is one of the important antioxidant enzymes that catalyze conversion of superoxide to hydrogen peroxide. The aim of present study is to measure the serum Malondialdehyde concentration and Superoxide dismutase activity in occupational workers.
Methods: A prospective study was carried out from October 2011 to May 2012 in collaboration between clinical biochemistry department at the College of Medicine-Hawler Medical University and chemistry department at the faculty of science and health at Koya University. Total of thirty non-office occupational workers were targeted, who exposed to air and industrial material pollutions, all individuals were healthy and non-alcoholics.
Results: The mean value of each of the serum Malondialdehyde concentration and serum Superoxide dismutase activity were significantly higher in occupational workers than that of non-occupational workers.
Conclusion: Based on findings of the present study it can be concluded that occupational works elevates the release of Superoxide dismutase enzyme, and also increases lipid peroxidation by reactive oxygen species which in turn causes elevation of Malondialdehyde.
Keywords: Serum Super oxide dismutase (SOD), serum malondialdehyde (MDA), oxidative stress, occupational works.
1. Sies H. Oxidative stress: from basic research to clinical application. Am J Med 1991; 91(3C): 315-85.
2. Cetinkaya A, Kurutas EB, Buyukbese MA, Kantarceken B, Bulbulo E. Levels of Malondialdehyde and Superoxide Dismutase in Subclinical Hyperthyroidism. Clin Chim Acta1999; 196:2-3.
3. Georgeson GD, Szony BJ, Streitman K. Antioxidant enzyme activities are decreased in preterm infants and in neonates born via caesarean section. Eur J Obstet Gynecol Reprod Biol 2002; 103(2):136-9.
4. Miral D, Pawel J. Mechanism of free radical-induced damage to DNA”. Free Radic Res 2012; 46:382-419.
5. Nakai A, Oya A, Kobe H. Changes in maternallipid peroxidation levels and antioxidant enzymatic activities before and after delivery. J Nippon Med Sch 2000; 67(6):434-9.
6. Loeper J, Goy J, Rozensztajn L, Bedu O, Moisson P. Lipid peroxidation and protective enzymes during myocardial infarction . Clin Chim Acta 1991; 196(2-3):119-25.
7. Armstrong D, Browne R. The analysis of free radicals, lipid peroxidases, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. Free Radic Diag Med 1994; 366:43-58.
8. Pryor WA, Stanley JP. Letter: A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. J Org Chem 1975; 40 (24): 3615–7.
9. Farmer EE, Davoine C. Reactive electrophile species. Curr Opin Plant Biol 2007; 10(4):380–6.
10. Lef’evre G. Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances. Annals de Biologie Clinique (Paris) 1998; 56(3):305-19.
11. Buddi R, Lin B, Atilano SR, Zorapapel NC, Kenney MC, Brown DJ. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem 2002; 50(5):240-52.
12. Tainer JA, Getzoff ED, Beem KM, Richardson JS, Richardson DC. "Determination and analysis of the 2 A-structure of copper, zinc superoxide dismutase". J Mol Biol 1982; 160(2):181–217.
13. Getzoff ED, Tainer JA, Weiner PK, Kollman PA, Richardson JS , Richardson DC. Electrostatic recognition between superoxide and copper, zinc superoxide dismutase. Nature 1983; 306:287-90.
14. Porntadavity S, Xu Y, Kiningham K, Rangnekar VM, Prachayasitikul V, St Clair DK . TPA-activated transcription of the human MnSOD gene: Role of transcription factors Sp-1 and Egr-1. DNA Cell Biol 2001; 20:473–8.
15. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek D, et al. Motor neurons inCu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 1996; 3:43–7.
16. Allen S, Badarau A, dennison C. Cu(I) affinities of the domain 1 and 3 sites in the human metallochaperone for Cu,Zn-supueroxide dismutase. Biochemistry 2012; 51:1439-48.
17. Williams MD, Van Remmen H, Conrad CC, Huang TT, Epstein CJ, Richardson A. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J Biol Chem 1998; 273:510–5.
18. Greenlund L. Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death. Neuron 1995; 14:303.
19. Deng L. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. . Science 1993; 261:986.
20. Venkataraman F. Manganese superoxide dismutaseoverexpression inhibits the growth of androgen-independent prostate cancer cells. Oncogene 2005; 24:77.
21. Navarro-Antolín. Role of peroxynitrite in endothelial damage mediated by Cyclosporine A. Free Radic Biol Med 2007; 42(3):394-403.
22. Jostana A Pl, Arun J P, Ajitt V S, Sajay P G. Oxidative stress and antioxidants status of occupational pesticides exposed sprayers of grape gardens of Western Maharashtra (India). Biochemstry J 2009; 9:2.
23. Rehncrona S, Smith DS, Akesson B, Westerberg E, Siesjo BK. Peroxidative changes in brain cortical fatty acids and phospholipids as characterized during Fe2+ and ascorbic acid-stimulated lipid peroxidation in vitro. J Neurochem 1980; 34: 1630–8.
24. Gerard MD, Erdelmcier J, Rengard K. Reaction of N-methyl-2-phenilindole with MDA and 4-hydroxy alkenals; analytical application to colorimetric assay of lipid peroxidationChem. Res Tox1997; 60(1):1176-83.
25. McCord JM, Fridovich I. Superoxide dismutase: the first twenty years (1968-1988). Free Radic Biol Med 1988; 5(5-6):363–9.
26. Mikhail FA, Susan P, Ledoux, Glenn L. Mitochondrial DNA and aging. Clinical Science 2004; 107:355-64.
27. Daniel WW. Biostatistics: A foundation for analysis in the health science. 3rd ed. USA: John Wiley and Sons; 1983. P. 123-27.
28. Sharifian A, Farahani S, Pasalar P. Shift workers as an oxidative stressor. JCR 2005; 3:15.
Background and objective: Posterior vitreous detachment is a common problem which may induce several potentially serious events. The aim of the study was to determine the prevalence of posterior vitreous detachment in Erbil and its distribution among different age groups also to determine its correlation to age, gender, smoking, blurring of vision, floater, flashes of light, diabetes mellitus and hypertension.
Methods: A cross-sectional study carried out on 150 persons (300 eyes) with mean age of 40 years attending Rizgary Teaching Hospital (Erbil, Iraq) who were referred for ultrasound examination for any indication other than eye problem. The patients were examined by ocular ultrasound unit equipped with a 7.5–10 MHz real-time linear high-frequency probe with the contact method.
Results: The prevalence of posterior vitreous detachment was 19.3%, with an extremely statistical significant association between posterior vitreous detachment and increasing age, diabetes, hypertension, blurred vision and floater, but no association with smoking, gender and flash of light.
Conclusion: Posterior vitreous detachment is a common disease its prevalence increases with advancing age with a strong association to blurred vision, floaters, diabetes mellitus and hypertension but no association with gender, smoking or ultrasound detected vitreous opacities.
Keywords: vitreous detachment, Ultrasound, Erbil.
1. Sebag J. The Vitreous: Structure, function, and pathobiology. New York: Springer-Verlag; 1989. P. 80–95.
2. Sebag J. Vitreous anatomy and pathology. In: Yanoff M, Duker J S, Augsburger J J, Azar D T, Diamond G R, Dutton JJ, et al. editors. Ophthalmology. 3rd ed. St Louis: Mosby; 2009. P. 766-73.
3. Johnson M W. Perifoveal vitreous detachment and its macular complications. Michigan: Trans Am OphthalmolSoc 2005; 103:537-67.
4. Jaffe NS. Complications of acute posterior vitreous detachment.Arch Ophthalmol1968; 79:568-71.
5. Foos RY, Wheeler NC. Vitreoretinal juncture: Synchysissenilis and posterior vitreous detachment. Ophthalmology1982; 89:1502–12
6. Wilkinson CP, Rice TA. Michels Retinal Detachment. 2nded. St Louis: Mosby; 1990: 30–4.
7. Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment.4th ed. St Louis: Mosby; 1997. P. 904-51.
8. Posterior Vitreous Detachment: Floaters and Flashes. Vitreous-Retina-Macula Consultants of New York. 2009 (Accessed 2012 Jan 7). Available from: http://www.vrmny.com/pe/pvd.html.
9. Novak M A, Welch RB. Complications of acute symptomatic posterior vitreous detachment.Am J Ophthalmol1984; 97:308-14.
10. Jaffe N S. Vitreous traction at the posterior pole of the fundus due to alternations in the vitreous posterior. Trans Am AcadOphthalmolOtolaryngol1967; 71:642-52.
11. Smiddy W E. Vitreomacular traction syndrome. In: Yanoff M, Duker J S, Augsburger J J, Azar D T, Diamond G R, Dutton JJ, et al, editors. Ophthalmology. 3rd ed. St Louis: Mosby; 2009. P.691–5.
12. Aironi V D, Gandage S G. Pictorial essay: B-scan ultrasonography in ocular abnormalities:Indian Journal of Radiology and Imaging 2009; 19(2):109–15.
13. Coleman J D. Ultrasonography of eye and orbit. 2nd ed. Lippincott: Williams and Wilkins; 2006. P. 47–122.
14. John AF. The eye and orbit. In: Cosgrove D, editors. Clinical Ultrasound.2nd ed. London: Elsevier; 2001. P. 659–95.
15. Ahmed A M. Ultrasonographic evaluation of the eye. High Diplomathesis in Diagnostic Radiology. Dohuk:Dohuk University, College of Medicine; 2009.
16.Johnson M W, Van Newkirk M R, Meyer K A. Perifoveal vitreous detachment is the primary pathogenic event in idiopathic macular hole formation. Arch Ophthalmol2001; 119: 215–22.
17. Van Newkirk M R, Gass JDM, Callanan D. Follow-up and ultrasonographic examination of patients with macular pseudo-operculum.Am J Ophthalmol1994; 117: 13–8.
18. Van Newkirk M R, Johnson M W, Hughes J R. B-scan ultrasonographic findings in the stages of idiopathic macular hole. Trans Am OphthalmolSoc2000; 98: 163–71.
19. Petrie A, Sabin C. Medical statistics at a glance.1st ed. London: Alden press; 2000. P. 64.
20. Dawood Z, Mirza S A, Qadeer A. Role of B-Scan Ultrasonography for Posterior Segment Lesions. J Liaquat.Uni Med Health Sci 2008; 7(1):7-12.
21.Hikichi T, Trempe C L. Relationship between floaters, light flashes, or both, and complications of posterior vitreous detachment.Am J Ophthalmol1994;117(5):593-8.
22. Schwab C, Ivastinovic D, Borkenstein A, Lackner E M, Wedrich A, Velikay M. Prevalence of early and late stages of physiologic PVD in emmetropic elderly population. ActaOphthalmol 2012; 90(3):e179-84.
23. Hayreh SS, Jonas JB. Posterior Vitreous Detachment: Clinical Correlations. Ophthalmologica2004; 218:333–43.
24. Weber-Krause B, Eckardt C. Incidence of posterior vitreous detachment in the elderly. Ophthalmology 1997; 94(9):619-23.
25. Tanner V, Harle D, Tan J, Foote B, Williamson T H,Chignell A H. Acute posterior vitreous detachment: the predictive value of vitreous pigment and symptomatology. Br J Ophthalmol2000; 84:1264-8.
26. Murakami K, Find all citations by this author (default) Or filter your current search Jalkh A E, Find all citations by this author (defau\Or filter your current search Avila M P, Find all citations by this author (default).Or filter your current search Trempe C L, Find all citations by this author (default).Or filter your current search Schepens C L. Vitreous floaters.Ophthalmology1983; 90(11): 1271-6.
27. McLeod D, Restori M. Ultrasound examination in severe diabetic eye disease. Br J ophthalmol 1979; 63:533-8.
Background and objective: Staphylococcus aureus (S. aureus) is responsible for a wide range of diseases and increased number of the strains that acquired resistance to antibiotics. The emergence of Vancomycin resistance of S. aureus has been a significant impact on human health. The distribution of Vancomycin minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) in S. aureus isolates, and compared antibiotic susceptibility to non-glycopeptideantibiotics in different Vancomycin MIC value groupswere assessed in this study.
Methods: S. aureuswere isolated by standard method and subjected to MIC tested by broth microdilution method for Vancomycin and eight non-glycopeptideantibiotics, alsoVancomycin MBCs were determined.
Results: Approximately 56% of S. aureus with a 0.5 µg/ml Vancomycin MIC were accounted, whereas 1.77% of S. aureushadan 8 µg/ml Vancomycin MIC. In other hand, most S. aureus had 1 and 2 µg/ml Vancomycin MBC.
Conclusion: About half of the S. aureus isolates had 0.5 µg/ml of Vancomycin MIC. Relationship between Vancomycin MIC and resistance to non-glycopeptideantibiotics were observed, with increased Vancomycin MIC, the resistance to others antibiotics also elevated, and vice versa.
Keywords: Vancomycin creep; Staphylococcus aureus; MRSA; MIC creep; Resistance
1. Fridkin SK. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 2001; 32(1):108-15.
2. Otto M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol 2010; 64:143-62.
3. Tsuji BT, Rybak MJ, Cheung CM, Amjad M, Kaatz GW. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. DiagnMicrobiol Infect Dis 2007; 58(1):41-7.
4. Palavecino E. Community-acquired methicillin-resistant Staphylococcus aureus infections.Clin Lab Med 2004; 24(2):403-18.
5. Kim HB, Lee YS, Kim BS, Cha JO, Kwon SU, Lee HJ, et al. Prevalence and clinical implications of Staphylococcus aureus with a vancomycin MIC of 4 microg/ml in Korea. Microb Drug Resist 2006; 12(1):33-8.
6. Wootton M, MacGowan AP, Walsh TR. Comparative bactericidal activities of daptomycin and vancomycin against glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA isolates. Antimicrob Agents Chemother 2006; 50(12):4195-7.
7. Monaco M, Sanchini A, Grundmann H, Pantosti A. Vancomycin-heteroresistant phenotype in invasive methicillin-resistant Staphylococcus aureus isolates belonging to spa type 041. Eur J ClinMicrobiol Infect Dis 2010; 29(7):771-7.
8. Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2000; 44(6):1549-55.
9. Boyle-Vavra S, Ereshefsky B, Wang CC, Daum RS. Successful multiresistant community-associated methicillin-resistant Staphylococcus aureus lineage from Taipei, Taiwan, that carries either the novel Staphylococcal chromosome cassette mec (SCCmec) type VT or SCCmec type IV. J ClinMicrobiol 2005; 43(9):4719-30.
10. Pillar CM, Draghi DC, Sheehan DJ, Sahm DF. Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States: findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance Programs. Diagn Microbiol Infect Dis 2008; 60(2):221-4.
11. Wang G, Hindler JF, Ward KW, Bruckner DA. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J ClinMicrobiol 2006; 44(11):3883-6.
12. Tacconelli E. Screening and isolation for infection control. J Hosp Infect2009; 73(4):371-7.
13. Alp E, Leblebicioglu H, Doganay M, Voss A. Infection control practice in countries with limited resources. Ann ClinMicrobiolAntimicrob 2011; 10:36.
14. Miyazaki M, Takata T, Yoshimura H, Matsunaga A, Ohta D, Ishikura H, et al. Vancomycin bactericidal activity as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureusbacteremia. Antimicrob Agents Chemother 2011; 55(4):1819-20.
15. Yamaguchi Y, Hanaki H, Yanagisawa C, Ikeda-Dantsuji Y, Hashimoto T, Yazaki H, et al. Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration. J Infect Chemother 2009; 15(5):274-8.
16. Appelbaum PC. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).Int J Antimicrob Agents 2007; 30(5):398-408.
17.Satola SW, Farley MM, Anderson KF, Patel JB. Comparison of detection methods for heteroresistantvancomycin-intermediate Staphylococcus aureus, with the population analysis profile method as the reference method. J ClinMicrobiol 2011; 49(1):177-83.
18. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011; 52(3):285-92.
19. Takesue Y, Nakajima K, Takahashi Y, Ichiki K, Ishihara M, Wada Y, et al. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia. J Infect Chemother 2011; 17(1):52-7.
20. Hawser SP, Bouchillon SK, Hoban DJ, Dowzicky M, Babinchak T. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009. Int J Antimicrob Agents 2011; 37(3):219-24.
21. Baddour MM, Abuelkheir MM, Fatani AJ. Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia. Ann ClinMicrobiolAntimicrob 2006; 5:30.
22. Tiwari HK, Sen MR. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect Dis 2006; 6:156.
23. Edwards B, Milne K, Lawes T, Cook I, Robb A, Gould IM. Is vancomycin MIC "creep" method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010. J Clin Microbiol 2012; 50(2):318-25.
24. Steinkraus G, White R, Friedrich L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus(VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05. J Antimicrob Chemother 2007; 60(4):788-94.
25. Voss A, Mouton JW, van Elzakker EP, Hendrix RG, Goessens W, Kluytmans JA, et al. A multi-center blinded study on the efficiency of phenotypic screening methods to detect glycopeptide intermediately susceptible Staphylococcus aureus (GISA) and heterogeneous GISA (h-GISA). Ann Clin Microbiol Antimicrob 2007; 6:9.
26. Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 2010; 23(1):99-139.
27. Srinivasan A, Dick JD, Perl TM. Vancomycin resistance in staphylococci. Clin Microbiol Rev 2002; 15(3):430-8.
28. Stefani S, Goglio A.Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance.Int J Infect Dis 2010; 14 (Suppl 4):19-22.
29. Walsh TR, Howe RA. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu Rev Microbiol 2002; 56:657-75.
30. Prakash V, Lewis JS II, Jorgensen JH. Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob Agents Chemother 2008; 52(12):4528.
31. Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, et al. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin Infect Dis 2003; 36:429-39.
32. Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, et al. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureusbacteremia. Clin Infect Dis 2008; 46(2):193-200.
33. Dhawan B, Gadepalli R, Rao C, Kapil A, Sreenivas V. Decreased susceptibility to vancomycin in meticillin-resistant Staphylococcus aureus: A 5 year study in an Indian tertiary hospital. J Med Microbiol 2010; 59(Pt 3):375-6.
34. Aguado JM, San-Juan R, Lalueza A, Sanz F, Rodríguez-Otero J, Gómez-Gonzalez C, et al. High vancomycin MIC and complicated methicillin-susceptible Staphylococcus aureus bacteremia. Emerg Infect Dis 2011; 17(6):1099-102.
35. Ho PL, Lo PY, Chow KH, Lau EH, Lai EL, Cheng VC, et al. Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong. J Infect 2010; 60(2):140-5.
36. Campanile F, Borbone S, Perez M, Bongiorno D, Cafiso V, Bertuccio T, et al. Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates. Int J Antimicrob Agents 2010; 36(5):415-9.
37. Dhand A, Sakoulas G. Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): Implications for therapy. F1000 Med Rep 2012; 4:4.
38. Vaudaux P, Huggler E, Bernard L, Ferry T, Renzoni A, Lew DP. Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to under detection of glycopeptide-intermediate isolates of Staphylococcus aureus. Antimicrob Agents Chemother 2010; 54(9):3861-70.
39. Griffiths JM, O'Neill AJ. Loss of function of the gdpP protein leads to joint β-lactam/glycopeptide tolerance in Staphylococcus aureus. Antimicrob Agents Chemother 2012; 56(1):579-81.
40. Harrison LS. Staphylococci. In: Mahon CR, Lehman DC, Manuselis G, editors. Textbook of diagnostic microbiology, 3rd ed. Philadelphia: Elsevier; 2007. P. 367-407.
41. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 8th ed. Approved Standard M07-A8. Wayne, PA, USA: CLSI; 2009.
42. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19. Wayne, PA, USA: CLSI: 2009.
43. French GL. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin. J Antimicrob Chemother 2006; 58(6):1107-17.
44. Honda H, Doern CD, Michael-Dunne W, Warren DK. The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia. BMC Infect Dis 2011; 11:335.
45. Sader HS, Fritsche TR, Jones RN. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Antimicrob Agents Chemother 2006; 50(7):2330-6.
46. National Committee for Clinical Laboratory Standards. Methods for Determining Bactericidal Activity of Antimicrobial Agents: Approved Standard M26-A. Villanova, PA, USA: NCCLS; 1999.
47. Vaudaux P, Lew DP. Tolerance of staphylococci to bactericidal antibiotics. Injury 2006; 37 (Suppl 2):15-9.
48. Archer GL. Staphylococcus aureus: A well-armed pathogen. Clin Infect Dis 1998; 26(5):1179-81.
49. Tang YW, Stratton CW. Staphylococcus aureus: An old pathogen with new weapons.Clin Lab Med 2010; 30(1):179-208.
50. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J ClinMicrobiol 2004; 42(6):2398-402.
51. Moise PA, Sakoulas G, Forrest A, Schentag JJ. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2007; 51(7):2582-6.
52. Tenover FC, Lancaster MV, Hill BC, Steward CD, Stocker SA, Hancock GA, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998; 36(4):1020-7.
53. Webster D, Rennie RP, Brosnikoff CL, Chui L, Brown C. Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada. Diagn Microbiol Infect Dis 2007; 57(2):177-81.
54. Saderi H, Owlia P, Shahrbanooie R. Vancomycin resistance among clinical isolates of Staphylococcus aureus. Arch Iranian Med 2005; 8(2):100-3.
55. Yeh YC, Yeh KM, Lin TY, Chiu SK, Yang YS, Wang YC, et al. Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia. J Microbiol Immunol Infect 2012; 45(3):214-20.
56. Denny AE, Peterson LR, Gerding DN, Hall WH. Serious staphylococcal infections with strains tolerant to bactericidal antibiotics. Arch Intern Med 1979; 139(9):1026-31.
57. Fitzgerald JR, Sturdevant DE, Mackie SM, Gill SR, Musser JM. Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc Natl Acad Sci 2001; 98(15):8821-6.
58. Choi EY, Huh JW, Lim CM, Koh Y, Kim SH, Choi SH, et al. Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia. Intensive Care Med 2011;37:639-6347.
Background and objective: Successful management of diabetes requires high degree of patient participation; this can be achieved by providing diabetic person with the knowledge and skills to perform self care on a day-to-day basis. This study aimed to assess the knowledge and practices of diabetic patients about diabetes in Erbil city.
Methods: A cross-sectional study was carried out during the period of April 2011 to April 2012 at Shahid Layla Qasm health center for diabetic care in Erbil city. The study involved a convenience sample of 400 diabetic patients aged ≥ 18 years old, both male and female. A specially designed questionnaire was used for data collection, which included socio-demographic characteristic of patients and other questions related to knowledge and practice about diabetes. SPSS was used for data entry and analysis.
Results: Out of 400 study subjects, 18 (4.5%) had good knowledge score, 209 (52.3%) had acceptable knowledge score, and 137 (43.3%) had poor knowledge score about the diabetes. A statistically significant association was found between knowledge levels and age of patients (P=0.02). This study also showed that, only 51 (12.8%) of patients had good practices, while 213 (53.3%) of them had acceptable practices and 136 (33.9%) had bad practices. A statistically significant association was found between practice levels with occupation (non manual skilled or semiskilled); (P value <0.001) and educational level (institute and more); (P value <0.001).
Conclusion: The rate of knowledge and practice was significantly associated with participants’ occupation and educational level. Those with low and acceptable knowledge had better practice than those who had good knowledge about diabetes.
Keywords: Knowledge, Practice, Diabetes, Diabetic Patients, Erbil.
1. Frier BM, Fisher B. Diabetes mellitus. In: Nicki R, Brisn R, Stuart H, (editors). Davidson᾽s principles & practice of Medicine. 21st Ed. Edinburgh. Churchill Livingstone Elsevier; 2010. P. 795-834.
2. Fried L. Epidmiology of aging. Epidemiology Reviews 2000; 22:95-106.
3. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes estimated for the years 2000 and projections for 2030. Diabetes Care 2004; 27(5):1047-63.
4. Christensen DL, Friis H, Mwaniki D, Kilonzo B, Tetens I, Boit M, et al. Prevalence of glucose intolerance and associated risk factors in rural and urban populations of different ethnic groups in Kenya. Diabetes Res Clin Pract 2009; 84(3): 303-10.
5. Mengel MB. Diabetes mellitus. In: Schwiebert L, (editor). Family Medicine Ambulatory Care &Prevention. 4th Ed. New York: McGaw-Hill; 2005. P. 476-83.
6. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 &2030. Diabetes Res Clin Pract 2010; 87:4-14.
7. American Diabetes Association. Diabetes mellitus and exercise. Diabetes Care 1997; 20:1908–12.
8. Mohan D, Raj D, Shanthiram CS. Awareness and Knowledge of diabetes in Chennai-The Chennai urban rural epidemiology study. J Assoc Physicians India 2005; 53:283-5.
9. KRSO. Kurdistan region population according to survey carried out by UNWFP at 2007, Erbil. Erbil statistical Department, 2007.
10. Palaian S, Acharya LD, Madhva Rao P, Shankar P, Nair N, Nair N P. Knowledge, Attitude, and Practice Outcomes: Evaluating the Impact of Counseling in Hospitalized Diabetic Patients in India. Pharmacy & Therapeutics Journal 2006; 31:382-95.
11. Upadhyay D, Palaian S, Shankar R, Mishra P. Knowledge, attitude and practice about Diabetes among Diabetes patients in Western Nepal. Rawal Med J 2008; 33(1):8-11.
12. Lewis RK, Lasack NL, Lambert BL, Conner SE. Patient counseling: A focus on maintenance therapy. Am J Health Syst Pharm 1997; 54: 2084-95.
13. Saadia Z, Rushdi S , Alsheha M, Saeed H, Rajab M. A Study of Knowledge Attitude and Practices of Saudi Women Towards Diabetes Mellitus. A (KAP) Study in Al-Qassim Region. I J H 2010; 11(2):1-7.
14. Ambigapathy R, Ambigapathy S, Ling HM. A knowledge, attitude and practice (KAP) study of diabetes mellitus among patients attending Klinik Kesihatan Seri Manjung. NCD Malaysia 2003; 2:6-16.
15. Maina W K, Ndegwa Z M, Njenga EW, Muchemi EW. Knowledge, attitude and practices related to diabetes among community members in four provinces in Kenya. AJDM 2011; 19(1):15-8.
16. Puepet FH, Mijinyawa BB, Akogu I, Azara I. Knowledge, attitude and practice of patients with Diabetes Mellitus before and after educational intervention in Jos, Nigeria. Journal of Medicine in the Tropics 2007; 9(1):3-10.
17. Shah V, Kamdar P, Shah N. Assessing the knowledge, attitudes and practice of type 2 diabetes among patients of Saurashtra region, Gujarat. Int J Diabetes Dev Ctries 2009; 29(3): 118-22.
18. Rafique G, Azam SI, White F. Diabetes knowledge, beliefs and practices among people with diabetes attending a university hospital in Karachi, Pakistan. E M H J 2006; 12(5):590-8.
19. Manus-Ruth Mc, Stitt L, Bargh G. Population survey of Diabetes knowledge and protective behaviours. Can J Diabetes 2006; 30(3):256-63.
20. Eknithiset R. Knowledge, attitude, and practice of diabetes mellitus type 2 patients in multidisciplinary program at diabetes mellitus clinic, phanomphrial hospital, phanomphrai district, Roi-Et province, Thailand J Health Res 2010; 24(2):87-92.
Background and objective: Tibial diaphyseal fracture is of two types, closed fracture, in which the skin is intact and open fracture in which the skin is injured. An open fracture is a type of fracture in which a break in the skin and underlying soft tissues communicates with the fracture and its haematoma .i.e. the fracture and its haematoma communicates with external environment. Our aim is to evaluate the treatment outcome of this structured protocol in terms of soft tissue injury healing and effective fracture stabilization by POP and external fixation, and to detect if there is any difference in time needed for union in both methods.
Methods: This is a comparative study done in Emergency hospital in Erbil – Kurdistan region, for management of open tibial diaphyseal fractures caused by gunshot injuries. The study included 50 patients of 18 to 65 years old. Patients were divided into two groups after debridment according to methods of treatment; group 1 was managed by POP, group 2 was managed by external fixation. The patients recruited and treated over 11 month period (August 2007 to June 2008).
Results: The study included 50 patients; 44 males (88%) and six females (12%). Their ages ranged between 18 years and 65 years with the mean age of 27.46 years. Patients divided into three groups according to Gustilo classification: GI included 8 patients (16%), GII included 34 patients (68%) and GIII included 8 patients (2A, 6B) (16%). There was significant difference between immobilization of open tibial diaphyseal fractures by pop and external fixation (P=0.001).
Conclusion: There will be delay union of the fractures when immobilized by external fixation. It is better to remove external fixature after 6 weeks and replace it by another method of immobilization of the fracture. Treatment of type III fracture is very difficult and needs long time, usually more than one year.
Keywords: split skin graft, external fixation , plaster of paris.
1. Shanker A, Ratra GS, Bhartendra J. Management of open fractures. Journal of Orthopaedics 2007; 4(1):e18.
2. Oscar P, Hampton JR. Orthopedic surgery in the Mediterranean theater of operations. Washington: US Government Printing Office; 1957.
3. Rowley D L. War wounds with fractures: A guide to surgical management. Geneva: ICRC: 1996.
4. Bowyer G. Débridement of extremity war wounds. J Acad Orthop Surg 2006; 14(10):S52-6.
5. Chapman MW, Szabo RM, Richard M. Chapmans orthopaedic surgery. 3rd edition. Philadelphia, Pa: Lippincott, Williams & Wilkins: 2000.
6. Gustilo RB, Anderson JT. Prevention of infection in the treatment of open fractures of long bones. J Bone Joint Surg Am 1976; 58:453-8.
7. Sam W, John N. Essentials of orthopaedic surgery. 3rd edition. New York: Springer Science and Business Media, LLC; 2007.
8. Warwick SL, David J, Selvadurai N. Apleys System of orthopedics and fractures, 8th edition. London: Arnold; 2001. p. 561.
9. Philip AF. Early management of open tibial fractures in Benin city. Journal of Medicine and Biomedical Research 2006; 5(12):33-9
10. Minoo P. Tibia fractures. Available from https:// www.emedicine.com/orthoped/topic 336.htm
11. Charalampos ZG, Randall ME, Levins L, Patzakis MJ. Management of open fracture and subsequent complication. Journal of Bone and Joint Surgery (American) 2007; 89:884-95.
Background and objective: Anaemia is often an unrecognized complication of diabetes mellitus that has adverse effect on the progression of diabetes related complications. Contributors to its development include erythropoietin insufficiency and iron deficiency. The aim of this study was to assess the prevalence of iron deficiency anaemia and anaemia of chronic disease among diabetic patients.
Methods: Over a period of six month from November 2010 to May 2011, 250 diabetic patients, attending Layla Qasim diabetic center were studied, their age ranged between 18-73 years. Venous blood samples were collected from each of them. A complete blood picture, iron study, HbA1c% and fasting blood glucose were performed. According to the duration of diabetes, patients were divided into three groups: group I patients (duration of diabetes < 5 years), group II (duration of diabetes between 5-9 years) and group III (duration of diabetes ≥10 years).
Results: One hundred ten patients (44%) were found to have anaemia. The frequency of anaemia was more among group III (46.6%). Higher prevalence of anaemia was found among female patients (53.9%) than male patient (24.1%). Among anemic patients, 72 patients (65%) considered as having anaemia of chronic disease (ACD), 26 patients (24%) were iron deficiency anemia (IDA), 11 patients (10%) were thalassemia trait and one patient (1%) had autoimmune hemolytic anaemia. ACD was more frequent among group II (80%) and group III (70.4%), while IDA was more frequent among group I (12.6%). both ACD and IDA were more frequent among female patient than male patients (34.7% and 13.8% respectively). There was no significant correlation between HbA1c and Hb, serum iron parameters and S.ferritin.
Conclusion: It was concluded that anaemia is common among diabetics and remains unrecognized by both physicians and patients; it is more common among female diabetics. The commonest type of anaemia among diabetic patients is ACD followed by IDA.
1. American Diabetes Association. Diagnosis and Classification of diabetes mellitus. Diabetes Care 2006; Supp 1:543-8.
2. Leu JP, Zonszein J. Diagnostic Criteria and Classification of Diabetes. In: Leonid Poretsky editors. Principles of Diabetes Mellitus. 2nd ed. New York: Springer; 2010. PP 107-15.
3. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Available at http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. [Accessed January 28, 2011]
4. Danaei G. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. The Lancet 2011; 378:31-40.
5. Thomas MC, Mac Isaac RJ, Salamandris T C, Power D, Jerums G. Unrecognized Anemia in Patients with Diabetes. Diabetes Care 2003; 26:1164-9.
6. Macdougall IC, Eckardt KU, Locatelli F. Latest US KDOQI Anaemia Guidelines update–what are the implications for Europe? Nephrol Dial Transplant; 2007; 22:2738-42.
7. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia – The Third National Health and Nutrition Examination Survey. Arch Intern Med 2002; 1401-8
8. Rathi MS, Woodrow G, Mansfield MW. Prevalence of anaemia and the contribution of functional iron deficiency in diabetes related chronic kidney disease. Pract Diab Int 2006; 27:102-4
9. Adetunji OR, Mani H, Olujohungbe A, Ronald J, Morgan C, Gill GV. Prevalence and characteristics of anaemia in diabetes. Pract Diab Int 2008; 25:110-3.
10. Cawood TJ, Buckly U, Murray A, Corbett A, Dillon D, Goodwin B. Prevalence of anaemia in patients with diabetes mellitus. Ir J Med Sci 2006; 175:25-7
11. Thomas S, Stevens PE. Anaemia in diabetic kidney disease: an area for improvement? Pract Diab Int 2006; 23:22-6.
12. Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care 2001; 24:495-9.
13. Coppack SW, Thursfield V, Dhar H, Hockaday TDR. Mild anemia is frequent and associated with micro- and macroangiopathies in patients with type 2 diabetes mellitus. JDI 2010; 1(6):273-8.
14. Bonakdaran S, Gharebaghi M, Vahedian M. Prevalence of anaemia in type 2 diabetes and role of renal involvement. Saudi J Kidney Dis Transpl 2011; 22:286-90.
15. Shi Z, Hu X, Yuan B, Pan X, Meyer HE, Holmboe-Ottesen G. Association between serum ferritin, haemoglobin, iron intake and diabetes in adults in Jiangsu, China. Diabetic Care 2006; 29:1878-83.
16. Almoznino-Sarafian D, Shteinshnaider M, Tzur I, Bar-Chaim A, Iskhakov E, Berman S, et al. Anaemia in diabetic patients at an internal medicine ward: Clinical correlation and prognostic significance. Eur J Intern Med 2011; 21:91-6.
17. Pasricha SR, Caruana SR, Phuc TQ, Casey GJ, Jolley D, Kingsland S, et al. Anemia, Iron deficiency, Meat consumption and Hookworm infection in women of reproductive age in northwest Vietnam. Am J Trop med Hyg 2008; 78:375-81.
Background and objective: Yellow nail syndrome is a rare clinical syndrome. Given the low number of known cases (approx. 200 cases described) and unclear disease etiology, no accepted standards of treatment exist.
Case report: A 65 years old man presented to Rizgary Teaching Hospital consultation department of internal medicine with shortness of breath, swelling of both upper and lower limbs and nail changes.
Keywords: Yellow nail syndrome, lymphedema.
1. Bokszczanin A, Levinson AI. coexistentyellow nail syndromeandselective antibody deficiency. Ann allergy Asthma Immunol 2003; 91:496-500.
2. Hershko A, Hirshberg B, Nahir M. Yellow nail syndrome. Postgrad Med J 1997; 73:466-8.
3. Hoque SR, Mansour S, Mortimer PS. Yellow nail syndrome: Not a genetic disorder? Eleven new cases and a review of theliterature. Br J Dermatol 2007; 156:1230-4.
4. Maldonado F, Ryu JH. Yellow nail syndrome. CurrOpinPulm Med 2009; 15:371-5.
5. Hiller E, Rosenow EC, Olsen AM. Pulmonary manifestationsof the yellow nail syndrome. Chest 1972; 61:452-8.
6. Emerson PA. Yellow nails, lymphedema, and pleural effusion.Thorax 1966; 21:247-53.
7. Ayres S, Mihan R. Yellow nail syndrome:response to vitamin E”. Arch Dermatol1973; 108(l2):267-8.
8. Cohen M, Sahn SA. Bronchiectasis in systemic diseases. Chest 1999; 116:1063-74.
9. Maldonado F, Tazelaar HD, Chilhowie W, Ryu JH. Yellownail syndrome. Analysis of 41 consecutive patients. Chest 2008; 134:375-81.
10. Machado RF, Rosa DJ, Leite CCA, Neto MPM, Gamonal A.Yellow nail syndrome-Case report. Ann Bras Dermatol 2009; 84:659-62.
11. Cimini C, Giunta R, Utili R, Durante-Mangoni E. Yellow nailsyndrome as a cause of unexplained edema. Monaldi Arch.Chest Dis 2009; 71:176-9.
12. D’Alessandro A, Muzi G, Monaco A, Filiberto S, Barboni A,Abbritti G. Yellow nail syndrome: does protein leakage playa role? EurRespir J 2001; 17:149-52.
13. Gupta AK, Davies GM, Haberman HF. “Yellow nail syndrome”. Cutis1986; 37(5):371-4.
14. Lambert EM, Dziura J, Kauls L, Mercurio M, Antaya RJ. Yellow nail syndrome in three siblings: A randomized double--blind trial of topical vitamin E. Pediatr Dermatol 2006; 23:390-5.
Background and objective: Hypoparathyroidism is an uncommon endocrine-deficiency disease characterized by low serum calcium levels, elevated serum phosphorus levels, and absent or inappropriately low levels of parathyroid hormone in the circulation. It is characterized by carpal and pedal muscle spasms, positive Chvostek's and Trousseau's signs. Diagnosis is done by typical clinical and laboratory findings. Current treatment options include oral calcium, vitamin D, and thiazide diuretics. We present a 21 years old girl exhibiting characteristic features of idiopathic hypoparathyroidism presented with nonunion fracture of right ulner bone.
1. Fong J, Khan A .Hypocalcemia, updates in diagnosis and management for primary care. Can Fam Physician2012; (58):158-62.
2. Rubin MR, Bilezikian JP. Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement. Endocrinol Metab2010; 54(2):220-6.
3. Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB Jr. Long-Term Treatment of Hypoparathyroidism: A Randomized Controlled Study Comparing Parathyroid HormoneVersus Calcitriol and Calcium. Clin Endocrinol Metab 2003; 88:4214-20.
4. Kazmi AS, Wall BM. Reversible Congestive Heart Failure Related to Profound Hypocalcemia Secondary to Hypoparathyroidism. Am J Med Sci 2007; 333(4):226-9.
5. Jithesh K, Narayanan Potti S, Sasidharan PK. Case Report: Idiopathic hypoparathyroidism presenting as Secondary myelofibrosis : A rare disease association. Clinical medicine update. 2006. (Accessed on 2 March 2013). Available from http://www.japi.org/october2006/CR-822.htm
6. Mamdani N, Repp AL, Seyoum B, Berhanu P. Idiopathic hypoparathyroidism presenting with severe hypocalcemia and asymptomatic basal ganglia calcification followed by acute intracerebral bleeding. Endocrine practice 2007; supplement 13(5):487-92.
7. Picon PD, Gadelha MIP, Beltrame A. Clinical Practice Guidelines for Pharmaceutical Treatment of Hypoparathyroidism. Ministry of Health, Department of Health Care Ordinance; 2010.
8. Potts JT. Diseases of the parathyroid gland and the hyper-and hypocalcemic disorders. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL. Harrison's principles of internal medicine, 16th ed. New York: McGraw-Hill Professional; 2005. pp: 2249-68.
Adeno cystic carcinoma of the larynx is very rare and concomitantly with the follicular thyroid carcinoma is not reported in the literature. This case was presented to our centre because of the stridor and small anterior neck mass. Evaluation of the case showed a subglottic mass with an enhanced right thyroid mass on the CT scan. The treatment was thyroidectomy followed by total laryngectomy and bilateral neck dissection. The histopathological study of the subglottic mass showed adeno cystic carcinoma and of the thyroid mass was follicular carcinoma. The adeno cystic carcinoma of the larynx is usually asymptomatic and it has the opportunity to invade deeply before the diagnosis. Proper evaluation of the head and neck is mandatory in any laryngeal lesion.
1. Martin AB, Laysan P. Scott-Browns Otolaryngology, Head and neck surgery. 7th ed. London: Hodder Arnold.; 2008. P. 2604.
2. Adriane PC. Malignant laryngeal lesions. Current diagnosis and treatment in otolaryngology-head and neck surgery. 2nd ed. USA: McGraw Hill LANGE; 2004. P. 463.
3. Tincani AJ, Del Negro A, Araújo PP. Management of salivary gland adenoid cystic carcinoma: institutional experience of a case series. Sao Paulo Med J 2006; 124(1):26-30.
4. Javadi M, Bafrouee FM, Mohseni M, Asghari A. Laryngeal adenoid cystic carcinoma in a child: a case report. Ear Nose Throat J 2002; 81(1):34-5.
5. Bernard H. Baily and Loves Short Practice of Surgery 24th ed. London: Hoddler headline group; 2006. P. 805.
6. Pitman KT, Johnson J, Myers E. Papillary thyroid carcinoma associated with squamous cell carcinoma of the head and neck: significance and treatment. Am J Otolaryngol 1996; 17:190-6.
7. Farrag T, Lin F, Cummings CH, Sciubba JJ, Koch WM, Flint PW, Tufano RP. Importance of routine evaluation of the thyroid gland prior to open partial laryngectomy. Arch Otolaryngol Head Neck Surg 2006; 132:1047-51.
8. Moran CA, Suster S, Koss MN. Primary adenoid cystic carcinoma of the larynx and lung. A clinicopathologic and immunohistochemical study of 16 cases. Cancer 1994; 73:1390-7.
9. Cotton RT, Seid AB. Management of extubution problem in the premature child: anterior cricoid spilt as an alternative to tracheotomy. Ann Otol Rhinol Laryngol 1989; 89:508.
10. Ganly I, Patel SG, Coleman M, Ghossein R, Carlson D, Shah JP. Malignant minor salivary gland tumors of the larynx. Arch Otolaryngol Head Neck Surg 2006; 132:767-70.
11. Dexemble P, Huth J, Rebufy M, Chabrol A. Cystic adenoid carcinoma of the larynx: two cases. Ann Otolaryngol Chir Cervicofac 2003; 120(4):244-8.
12. Kufeld M, Junker K, Sudhoff H, Dazer S. Collision tumor of a hypopharyngealadenoidcystic carcinoma and a laryngeal squamous cell carcinoma. Laryngorhinootologie 2004; 83(1):51-4.